WHO to decide on emergency use listing for mpox vaccine in three weeks

The World Health Organization (WHO) is expected to make a decision on the issuance of an emergency use listing (EUL) for mpox vaccine within the next three weeks. WHO Director-General Dr. Tedros Adhanom Ghebreyesus made the announcement during the opening of the WHO Africa regional conference on Monday follow ing the submission of all required information by the vaccine manufacturer Dr.

Tedros stated, “The WHO will decide on whether to issue an emergency use listing (EUL) for an mpox vaccine within three weeks after its manufacturer supplied the global body with all the required information last Friday.” Related Stories Germany donates 100,000 Mpox Vaccine doses to combat outbreak in Africa Africa CDC to secure about 23 million Mpox vaccine doses to combat spread EUL is a process established by the World Health Organization (WHO) to expedite the evaluation and authorization of vaccines, diagnostics, and treatments in response to public health emergencies. Dr.

Tedros also highlighted the need for approximately $135 million to bring the current mpox outbreaks in Africa under control. He emphasized that this effort would require a “complex, comprehensive, and coordinated international response.” The WHO has faced criticism for its perceived delay in evaluating mpox vaccines that have already been approved in the United States and Europe.

This delay has left African countries reliant on donated vaccines. Nairametrics reported that Germany would donate 100,000 mpox vaccine.